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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Dermatology is the second least-diverse field in medicine, sec-
ond to orthopedic surgery (Pritchett et al., 2018). The American
Association of Medical Colleges (2004) defines underrepresented
in medicine (UIM) as racial and ethnic groups that are not repre-
sented in medicine relative to their percentage in the U.S. popula-
tion; this includes African Americans/blacks, Mexican Americans,
Native Americans, and mainland Puerto Ricans. This is an issue
not only for inclusive representation in our field, but also for the
optimal care of our increasingly diverse patient population. By
2044, the majority of the U.S. population will be composed of peo-
ple of color (Colby and Ortman, 2014). Patients from racial minor-
ity groups are more satisfied with the care they receive and are
more likely to adhere to medical treatments from race-concordant
physicians (National Resident Matching Program, 2018). Thus, to
provide the best care to our increasingly diverse population, we
must prioritize diversifying our physician workforce.
Although there is a variety of ongoing efforts to improve diver-
sity in dermatology, much work remains to be done to ensure that
our specialty closely reflects the patient population it serves. To
effectively improve diversity and inclusivity of dermatology, we
must understand potential barriers. In this article, we assert that
one step toward improving diversity and inclusivity in our field
would be to end reliance and stratification of applicants based on
the U.S. Medical Licensing Examination (USMLE) Step 1 numerical
score.
Dermatology is one of the most competitive residencies into
which one can match. A variety of attributes is commonplace
among dermatology applicants, but one commonality is a high
USMLE Step 1 score. The current average Step 1 score of U.S. allo-
pathic seniors who matched to dermatology is 249 (Cooper et al.,
2003). A recent proposal to change USMLE Step 1 to a pass–fail
examination has sparked a debate among dermatology educators.
Although many program directors may be hesitant to embrace this
change because of the utility of using USMLE Step 1 scores to adju-
dicate applicants, we propose that the use of USMLE Step 1 score
for residency selection contributes to the racial disparity in the
dermatology workforce. Less reliance on this assessment would
help ameliorate its negative impact on diversity in dermatology.
The focus on USMLE Step 1 scores in dermatology has had a
detrimental impact on selecting diverse medical students for resi-
dency. The USMLE Step 1 was implemented in 1992 with the pri-
mary intention of state licensure. The numerical score was never
designed to be used by program directors as a tool for residencyselection/screening (Colby and Ortman, 2014). Changing Step 1
to an entirely pass–fail format to limit unintended secondary pur-
poses has been discussed significantly in recent years. The Step 1
climate has been discussed by medical students because prepara-
tion for the examination negatively affects medical school educa-
tion, diversity, and wellness (Chen et al., 2019). A recent National
Board of Medical Examiners (2018) study showed that female
medical students scored 5.9 points lower on USMLE Step 1 and
Asian, Hispanic, and black students scored 4.5, 12.1, and 16.6
points lower than white male medical students, respectively.
UIMs may have lower average scores due to the cost of obtain-
ing the commercial products used for Step 1 preparation, which on
average require $1500 to $2000 in addition to the registration cost
of approximately $700 (Chen et al., 2019). Additionally, standard-
ized tests, such as USMLE Step 1, are biased against historically dis-
advantaged groups such as UIMs and have the deleterious effect of
continuing to benefit students from wealthier socioeconomic back-
grounds. Sociological studies have shown that racial differences in
average standardized test scores are evident beginning early in
school, with Hispanic and African-American children scoring
below Caucasian and Asian children; this is thought to be sec-
ondary to socioeconomic status based on parental education and
family income. This trend continues into higher education, such
as medical school, where UIMs continue to score lower than their
peers (Grodsky et al., 2008).
Dermatology faculty and program directors can agree to take
such differences into account during application reviews, but this
may already be too late. Even before this stage, we must consider
the hesitancy to pursue dermatology that our UIM students may
feel upon receiving their Step 1 score. A survey of 155 UIM stu-
dents across U.S. medical schools showed that they considered
USMLE Step 1 to be a significant deciding factor in their pursuit
of dermatology (Soliman et al., 2019). The implication is that UIMs
who may have scored lower may not even consider dermatology
because their score is sobering.
Even if UIMs do apply to dermatology with a lower score, some
program directors use the score to screen and rank dermatology
applicants despite a lack of evidence that Step 1 scores correlate
with clinical competence (Chen et al., 2019). Although multiple
studies have demonstrated a correlation between USMLE Step 1
scores and other specialty board examinations, there is a lack of
such evidence available for dermatology boards. A recent study
demonstrated a moderate correlation between Step 1 score and
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to suggest that Step 1 predicts dermatology board success
(Fening et al., 2011). Because dermatology programs receive a large
number of applications, easily usable and efficient screening tools
are often used to whittle the field of applicants. These objective
and distinct metrics may make application review more efficient,
but we assert that, as a result of this objective measure, we are
missing out on diverse and stellar applicants, which ultimately
perpetuates the lack of diversity in dermatology and contributes
to disparities in patient care.
We believe that moving away from focusing on the USMLE Step
1 numerical score and using the test as originally intended (i.e., a
marker for licensure) would improve diversity and inclusion in
dermatology. This approach would require program directors to
find alternative methods to evaluate applicants, such as individual
characteristics, research experience, and the clinical needs of the
residency program (Conrad et al., 2016; Pritchett et al., 2018).
Program directors should consider the holistic review process in
the selection of dermatology residents, akin to the approach that
many undergraduate medical schools are increasingly adopting
to increase diversity in their student bodies. Endorsed by the Asso-
ciation of American Medical Colleges as a model for medical school
admissions, the holistic review ensures that applications of all
qualified candidates are carefully evaluated in several domains
and measured against the specific mission of the institution
(Conrad et al., 2016). This requires program directors to consider
other relevant measures, including personal statement, goals of
addressing health care disparities, cultural competence, and com-
munity service activities (Conrad et al., 2016; Pritchett et al.,
2018). Using this approach will likely result in the selection of
diverse candidates for dermatology residency.
We understand that this type of intensive review of applications
would require more time and resources. However, the alternative
is costly, both to the medical education system and to our patients’
lives. It prevents a more diverse physician workforce composed of
individuals from different racial and ethnic backgrounds from tak-
ing care of an increasingly diverse patient population that evidence
has shown does better with increased race concordance.
Lack of diversity in dermatology has been discussed signifi-
cantly in recent years. Program directors must reconsider the use
of USMLE Step 1 in their selection process and use other factors
that may be more relevant to an applicant’s potential to be a highly
skilled and compassionate physician. Such change would allow
mentors and program directors to feel comfortable advising and
encouraging students with lower Step 1 scores to still consider der-
matology as a career choice as opposed to eliminating the field as
an option based solely on test scores. Additionally, program direc-
tors can lead the charge by insisting on application reform and
meaningful selection processes, such as a holistic review, that
would improve the diversity crisis in dermatology. Rethinking
our usage of USMLE Step 1 solely for licensing purposes will not
completely resolve the lack of UIMs in dermatology, but it is a
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